Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2007; 13(7): 985-992
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.985
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.985
Endogenous status of p53 or its pathways | Probable mechanisms |
Mutation of p53 gene | Point mutation, allele deletion, insertion, etc. |
Loss of or decrease in wt-p53 expression | Enhanced p53 degradation, complex formation |
Hyperactivities of negative regulators of p53 | No p53 mutation, over- expressed negative regulators of p53 attenuate its function |
Increased diversity of p53 aberration | Progression of HCC |
Presence of serum anti-p53 antibodies | Over-expression of wt-p53, presence of mt-p53, or both |
-
Citation: Guan YS, La Z, Yang L, He Q, Li P. p53 gene in treatment of hepatic carcinoma:
Status quo . World J Gastroenterol 2007; 13(7): 985-992 - URL: https://www.wjgnet.com/1007-9327/full/v13/i7/985.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i7.985